{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:23:03Z","timestamp":1744777383305,"version":"3.40.4"},"reference-count":133,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443238321"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.pmbts.2024.03.002","type":"book-chapter","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T03:01:01Z","timestamp":1710817261000},"page":"171-214","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19: Perspectives on innate immune evasion"],"prefix":"10.1016","author":[{"given":"Alaa A.A.","family":"Aljabali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Tanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debmalya","family":"Barh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murtaza M.","family":"Tambuwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2024.03.002_bib1","series-title":"Fenner\u2019s Veterinary Virology","first-page":"79","article-title":"Chapter 4\u2014Antiviral immunity and virus vaccines","year":"2017"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib2","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.73.10.8469-8475.1999","article-title":"Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway","volume":"73","author":"Heim","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/21505594.2021.1898169","article-title":"Pathogenicity and virulence of ebolaviruses with species- and variant-specificity","volume":"12","author":"Yamaoka","year":"2021","journal-title":"Virulence"},{"issue":"Suppl. 2","key":"10.1016\/bs.pmbts.2024.03.002_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1863-2378.2012.01454.x","article-title":"How Ebola virus counters the interferon system","volume":"59","author":"K\u00fchl","year":"2012","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib5","doi-asserted-by":"crossref","first-page":"1004608","DOI":"10.3389\/fcimb.2022.1004608","article-title":"Innate and adaptive immune evasion by dengue virus","volume":"12","author":"Lee","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/jir.2014.0129","article-title":"Dengue virus control of type I IFN responses: A history of manipulation and control","volume":"35","author":"Castillo Ramirez","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41426-018-0168-0","article-title":"Dengue virus and the host innate immune response","volume":"7","author":"Uno","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/v8080231","article-title":"Subversion of the immune response by rabies virus","volume":"8","author":"Scott","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib9","first-page":"751","article-title":"Genome-wide transcriptional profiling reveals two distinct outcomes in central nervous system infections of rabies virus","volume":"7","author":"Zhang","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11357-017-9986-6","article-title":"CMV immune evasion and manipulation of the immune system with aging","volume":"39","author":"Jackson","year":"2017","journal-title":"Geroscience"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib11","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.1800171","article-title":"Cytomegalovirus: Shape-shifting the immune system","volume":"200","author":"Picarda","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib12","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.74.16.7478-7484.2000","article-title":"Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha\/Beta interferon production","volume":"74","author":"Naniche","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/v14122641","article-title":"Measles virus-induced host immunity and mechanisms of viral evasion","volume":"14","author":"Amurri","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib14","first-page":"155","article-title":"Varicella zoster virus immune evasion strategies","volume":"342","author":"Abendroth","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib15","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/infdis\/jiy403","article-title":"Immunobiology of Varicella-Zoster virus infection","volume":"218","author":"Laing","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib16","first-page":"1","article-title":"Origins and diversification of animal innate immune responses against viral infections","author":"Iwama","year":"2023","journal-title":"Nat Ecol Evol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/cells10020300","article-title":"Mechanisms of coronavirus nsp1-mediated control of host and viral gene expression","volume":"10","author":"Nakagawa","year":"2021","journal-title":"Cells"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061339","article-title":"SARS-CoV-2: a master of immune evasion","volume":"10","author":"Rubio-Casillas","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167265","article-title":"Mechanisms of antiviral immune evasion of SARS-CoV-2","volume":"434","author":"Beyer","year":"2022","journal-title":"J Mol Biol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib21","series-title":"COVID-19","first-page":"19","article-title":"Biology of coronaviruses and predicted origin of SARS-CoV-2","author":"Pal\u00f9","year":"2022"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib22","first-page":"1258","article-title":"Pattern-recognition receptors in endometriosis: a narrative review","volume":"14","author":"Guo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41232-023-00259-5","article-title":"Innate immune recognition against SARS-CoV-2","volume":"43","author":"Yamada","year":"2023","journal-title":"Inflamm Regen"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib24","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/jmv.26826","article-title":"Role of Toll-like receptors in the pathogenesis of COVID-19","volume":"93","author":"Khanmohammadi","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/v13112302","article-title":"An overview of recent insights into the response of TLR to SARS-CoV-2 infection and the potential of TLR agonists as SARS-CoV-2 vaccine adjuvants","volume":"13","author":"Kayesh","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib26","article-title":"Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9091820","article-title":"TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection","volume":"9","author":"Bortolotti","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib29","doi-asserted-by":"crossref","first-page":"8874339","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and Toll-Like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediators Inflamm"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib30","doi-asserted-by":"crossref","DOI":"10.2217\/fvl-2021-0249","article-title":"Toll-like receptor 4 in COVID-19: friend or foe?","author":"Mukherjee","year":"2022","journal-title":"Future Virol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib31","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/jmv.25997","article-title":"Consider TLR5 for new therapeutic development against COVID-19","volume":"92","author":"Chakraborty","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib32","article-title":"TLR9 and COVID-19: a multidisciplinary theory of a multifaceted therapeutic target","volume":"11","author":"Bezemer","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib33","article-title":"Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.948770","article-title":"Toll-like receptor signaling in severe acute respiratory syndrome coronavirus 2-induced innate immune responses and the potential application value of Toll-like receptor immunomodulators in patients with coronavirus disease 2019","volume":"13","author":"Dai","year":"2022","journal-title":"Front Microbiology"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib35","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1073\/pnas.1324266111","article-title":"Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection","volume":"111","author":"Lee","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib36","series-title":"Coronavirus Therapeutics\u2013Volume I: Basic Science and Therapy Development","first-page":"87","article-title":"Toll-like receptors (TLRs) as therapeutic targets for treating SARS-CoV-2: an immunobiological perspective","author":"Patra","year":"2022"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib37","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/ijms22030992","article-title":"Can SARS-CoV-2 virus use multiple receptors to enter host cells?","volume":"22","author":"Gadanec","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/pathogens11020134","article-title":"The relevance of TLR8 in viral infections","volume":"11","author":"Mart\u00ednez-Espinoza","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2021.815388","article-title":"SARS-CoV-2 and the host cell: a tale of interactions","volume":"1","author":"Pizzato","year":"2022","journal-title":"Front Virology"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib40","article-title":"Coronaviral infection and interferon response: the virus-host arms race and COVID-19","volume":"14","author":"Liu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib41","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ymthe.2022.02.014","article-title":"The battle between host and SARS-CoV-2: innate immunity and viral evasion strategies","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41431-022-01108-8","article-title":"A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection","volume":"30","author":"Jamison","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12964-023-01104-5","article-title":"Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases","volume":"21","author":"Kakavandi","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib44","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/eji.200526149","article-title":"TLR8 and TLR7 are involved in the host\u2019s immune response to human parechovirus 1","volume":"35","author":"Triantafilou","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib45","article-title":"SARS Coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6","volume":"17","author":"Li","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib46","article-title":"Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner","volume":"4455","author":"Ran","year":"2022","journal-title":"Front Immunology"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10030501","article-title":"Innate immune response in SARS-CoV-2 infection","volume":"10","author":"Schiuma","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030530","article-title":"SARS-CoV-2 nucleocapsid protein targets RIG-I-like receptor pathways to inhibit the induction of interferon response","volume":"10","author":"Oh","year":"2021","journal-title":"Cells"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940756","article-title":"Roles and functions of SARS-CoV-2 proteins in host immune evasion","volume":"13","author":"Rashid","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253089","article-title":"SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms","volume":"16","author":"Vazquez","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41580-021-00430-1","article-title":"Cellular origins of dsRNA, their recognition and consequences","volume":"23","author":"Chen","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib53","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1073\/pnas.1921485117","article-title":"Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors","volume":"117","author":"Hackbart","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166671","article-title":"Insight into the mechanisms of coronaviruses evading host innate immunity","volume":"1869","author":"Yao","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib55","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-022-00884-5","article-title":"Structural biology of SARS-CoV-2: open the door for novel therapies","volume":"7","author":"Yan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib56","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1002\/mef2.29","article-title":"SARS-CoV-2 modulation of RIG-I-MAVS signaling: potential mechanisms of impairment on host antiviral immunity and therapeutic approaches","volume":"1","author":"Wang","year":"2022","journal-title":"MedComm \u2013 Future Med"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/v14091991","article-title":"SARS-CoV-2 non-structural proteins and their roles in host immune evasion","volume":"14","author":"Low","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12275-022-1525-1","article-title":"SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways","volume":"60","author":"Oh","year":"2022","journal-title":"J Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12985-022-01783-5","article-title":"The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity","volume":"19","author":"Gu","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib60","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.jaci.2009.07.016","article-title":"Innate immunity","volume":"125","author":"Turvey","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib61","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ymthe.2022.02.014","article-title":"The battle between host and SARS-CoV-2: innate immunity and viral evasion strategies","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib62","article-title":"Innate immunity evasion strategies of highly pathogenic coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2","volume":"12","author":"Li","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib63","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41564-019-0421-x","article-title":"Decoding type I and III interferon signalling during viral infection","volume":"4","author":"Mesev","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1172000","article-title":"Reprogramming viral immune evasion for a rational design of next-generation vaccines for RNA viruses","volume":"14","author":"Su","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib65","article-title":"Type I interferons in COVID-19 pathogenesis","volume":"10","author":"Palermo","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib66","article-title":"Virus caused imbalance of type I IFN responses and inflammation in COVID-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib67","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3389\/fimmu.2022.888897","article-title":"Dysregulated interferon response and immune hyperactivation in severe COVID-19: targeting stats as a novel therapeutic strategy","volume":"13","author":"Eskandarian Boroujeni","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response","volume":"16","author":"Sa Ribero","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119353","article-title":"SARS-CoV-2 evasion of the interferon system: can we restore its effectiveness?","volume":"24","author":"Sacchi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib70","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.7150\/ijbs.72482","article-title":"SARS-CoV-2 and the nucleus","volume":"18","author":"Chen","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655528","article-title":"Revisiting pleiotropic effects of type I interferons: rationale for its prophylactic and therapeutic use against SARS-CoV-2","volume":"12","author":"Garcia-Del-Barco","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib72","first-page":"178","article-title":"Innate immune evasion strategies of SARS-CoV-2","volume":"21","author":"Minkoff","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib73","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1016\/j.csbj.2021.07.023","article-title":"Immune evasion of SARS-CoV-2 from interferon antiviral system","volume":"19","author":"Min","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/v12040377","article-title":"IRF7 is required for the second phase interferon induction during influenza virus infection in human lung epithelia","volume":"12","author":"Wu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib75","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2019.00325","article-title":"Regulating IRFs in IFN driven disease","volume":"10","author":"Jefferies","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib76","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00430-019-00623-8","article-title":"Defective interferon priming and impaired antiviral responses in a patient with an IRF7 variant and severe influenza","volume":"208","author":"Thomsen","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib77","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib78","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/intimm\/dxh318","article-title":"Regulation of the type I IFN induction: a current view","volume":"17","author":"Honda","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib79","doi-asserted-by":"crossref","first-page":"e1000607","DOI":"10.1371\/journal.ppat.1000607","article-title":"Induction of IFN-\u03b2 and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7","volume":"5","author":"Daffis","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003773","article-title":"Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia","volume":"9","author":"Crotta","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib81","doi-asserted-by":"crossref","first-page":"13206","DOI":"10.1074\/jbc.M116.718080","article-title":"The type I interferon-IRF7 axis mediates transcriptional expression of Usp25 gene","volume":"291","author":"Ren","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009220","article-title":"Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses","volume":"17","author":"Feng","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib83","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3389\/fimmu.2018.03086","article-title":"The molecular basis of viral inhibition of IRF-and STAT-dependent immune responses","volume":"9","author":"Chiang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib84","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10787-022-00992-2","article-title":"COVID-19 and the role of cytokines in this disease","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.844447","article-title":"Uncovering novel viral innate immune evasion strategies: what has SARS-CoV-2 taught us?","volume":"13","author":"Tay","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib86","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the human innate immune system","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib87","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.13523","article-title":"Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage","volume":"202","author":"Amor","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib88","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2613.2001.00204.x","article-title":"Viral escape mechanisms\u2014escapology taught by viruses","volume":"82","author":"Lucas","year":"2001","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58020248","article-title":"Host defenses to viruses: lessons from inborn errors of immunity","volume":"58","author":"Leonardi","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib90","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nri2436","article-title":"Viral evasion and subversion of pattern-recognition receptor signalling","volume":"8","author":"Bowie","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114316","article-title":"Detection of viral infections by innate immunity","volume":"183","author":"Carty","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib93","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib94","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/v11060572","article-title":"Modulation of innate immune signaling pathways by herpesviruses","volume":"11","author":"Liu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib96","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/v1030737","article-title":"Activation and evasion of innate antiviral immunity by herpes simplex virus","volume":"1","author":"Melchjorsen","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mib.2016.05.015","article-title":"Innate immune evasion strategies of DNA and RNA viruses","volume":"32","author":"Beachboard","year":"2016","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib98","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/v3060920","article-title":"Pattern recognition receptors and the innate immune response to viral infection","volume":"3","author":"Thompson","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib99","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib100","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658896","article-title":"Cytokine overproduction and immune system dysregulation in alloHSCT and COVID-19 patients","volume":"12","author":"Lange","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.752214","article-title":"Coronavirus Nsp1: immune response suppression and protein expression inhibition","volume":"12","author":"Yuan","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2022.02.014","article-title":"The battle between host and SARS-CoV-2: innate immunity and viral evasion strategies","author":"Zhang","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib104","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","article-title":"Structures and functions of coronavirus replication\u2013transcription complexes and their relevance for SARS-CoV-2 drug design","volume":"23","author":"Malone","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib105","article-title":"Understanding the role of SARS-CoV-2 ORF3a in viral pathogenesis and COVID-19","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib106","article-title":"ISGylation in innate antiviral immunity and pathogen defense responses: a review","volume":"3196","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib107","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00018-020-03671-z","article-title":"Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway","volume":"78","author":"Rojas","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib108","doi-asserted-by":"crossref","first-page":"e28561","DOI":"10.1002\/jmv.28561","article-title":"SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I\/MDA5, TRIF, and STING signaling pathways","volume":"95","author":"Deng","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib109","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4048\/jbc.2021.24.e34","article-title":"The role of STAT1 in T helper cell differentiation during breast cancer progression","volume":"24","author":"Banik","year":"2021","journal-title":"J Breast Cancer"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib110","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1128\/JVI.01012-07","article-title":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum\/Golgi membrane","volume":"81","author":"Frieman","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113889","article-title":"The role of SARS-CoV-2 accessory proteins in immune evasion","volume":"156","author":"Zandi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib112","doi-asserted-by":"crossref","first-page":"1035559","DOI":"10.3389\/fimmu.2022.1035559","article-title":"SARS-CoV-2 ORF8: one protein, seemingly one structure, and many functions","volume":"13","author":"Vinjamuri","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib113","article-title":"The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-\u0399","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib114","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.13523","article-title":"Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage","volume":"202","author":"Amor","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035559","article-title":"SARS-CoV-2 ORF8: one protein, seemingly one structure, and many functions","volume":"13","author":"Vinjamuri","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib116","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of immune response during SARS-CoV-2 infection: lessons from the past","volume":"11","author":"Shah","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib117","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijid.2020.09.015","article-title":"Antibody-dependent enhancement of coronavirus","volume":"100","author":"Wen","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib118","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/v15041000","article-title":"The envelope (E) protein of SARS-CoV-2 as a pharmacological target","volume":"15","author":"Santos-Mendoza","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib120","doi-asserted-by":"crossref","first-page":"e2164219","DOI":"10.1080\/22221751.2022.2164219","article-title":"The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development","volume":"12","author":"Yu","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib121","doi-asserted-by":"crossref","first-page":"342","DOI":"10.20411\/pai.v5i1.377","article-title":"The structure of the membrane protein of SARS-CoV-2 resembles the sugar transporter semiSWEET","volume":"5","author":"Thomas","year":"2020","journal-title":"Pathog Immun"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10091218","article-title":"Biology and pathogenesis of SARS-CoV-2: understandings for therapeutic developments against COVID-19","volume":"10","author":"Sharma","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113889","article-title":"The role of SARS-CoV-2 accessory proteins in immune evasion","volume":"156","author":"Zandi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib124","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208525120","article-title":"SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression","volume":"120","author":"Arshad","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib125","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/s41467-021-23118-8","article-title":"Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions","volume":"12","author":"Gao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib126","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7150\/ijbs.59272","article-title":"Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy","volume":"18","author":"Jiang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101672","article-title":"Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies","author":"Tiwari","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/v14061247","article-title":"Characterization of SARS-CoV-2 evasion: interferon pathway and therapeutic options","volume":"14","author":"Znaidia","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113008","article-title":"Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and microRNAs","volume":"164","author":"Seneff","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib131","article-title":"Exploration of pattern recognition receptor agonists as candidate adjuvants","volume":"968","author":"Ong","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 vaccine: a comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/bs.pmbts.2024.03.002_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.12.011","article-title":"COVID-19 vaccines: the status and perspectives in delivery points of view","volume":"170","author":"Chung","year":"2021","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Progress in Molecular Biology and Translational Science","Navigating the Complexities of SARS-CoV-2 Immunobiology: The Science Behind the COVID-19 Pandemic"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:34:00Z","timestamp":1744731240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117324000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443238321"],"references-count":133,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2024.03.002","relation":{},"ISSN":["1877-1173"],"issn-type":[{"type":"print","value":"1877-1173"}],"subject":[],"published":{"date-parts":[[2025]]}}}